ADHD

The Pharmacy Times® Attention-Deficit Hyperactivity Disorder (ADHD) Resource Center is a comprehensive resource for clinical news and expert insights on issues related to ADHD, a chronic condition that can cause attention difficulty, hyperactivity, and impulsiveness.

Latest News

FDA approval stamp -- Image credit: Surendra | stock.adobe.com
FDA Approves Clonidine Hydrochloride For Treatment of ADHD in Pediatric Patients

May 29th 2024

The treatment is the first liquid non-stimulant for attention deficit hyperactivity disorder to be approved in the United States.

Image credit: Yakobchuk Olena | stock.adobe.com
Prenatal Exposure to General Anesthesia Increases Risk of Subsequent ADHD, Behavioral Disorder Diagnosis

March 5th 2024

Young black pharmacist assists senior woman in buying medicine in pharmacy. | Image Credit: Drazen - stock.adobe.com
Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages

September 22nd 2023

Pharmacists Play a Critical Role in Protecting Patients From Illegal Online Drug Sellers
Pharmacists Play a Critical Role in Protecting Patients From Illegal Online Drug Sellers

August 1st 2023

Image credit: BillionPhotos.com - stock.adobe.com
Anticipating Drug Shortages During Supply Chain Disruptions: Implications for Children With ADHD

July 25th 2023

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.